Several recent reports have raised the possibility that the apolipoproteins have been proposed as a better index for predicting the risk of cardiovascular disease than the traditional lipid parameters for CHD, based on the premise that apoB levels better reflect the number of atherogenic lipoprotein particles in a given volume of plasma [14], [15], [20], [21], [27], whereas other studies do not support this notion [16]–[18], [22]. This evidence concerns the gene APOB and coronary artery disorder.